Patent directory · USPTO A61K / A61P
Patents matching “inhibitors”
2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11466018
TGF-β inhibitors
granted -
US 11464856
Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers
granted -
US 11459340
Tri-substituted heteroaryl derivatives as Src homology-2 phosphatase inhibitors
granted -
US 11459308
Broad spectrum inhibitors of filoviruses
granted -
US 11453668
JAK inhibitors containing a 4-membered heterocyclic amide
granted -
US 11453683
KRas G12D inhibitors
granted -
US 11452714
Antibacterial agents including histidine kinase inhibitors
granted -
US 11452780
Mtorc1 inhibitors
granted -
US 11439641
Pyrimidine JAK inhibitors for the treatment of skin diseases
granted -
US 11439632
Use of neuronal nitric oxide synthase inhibitors for immunotherapy in melanoma patients
granted -
US 11439629
Methods for the administration of certain VMAT2 inhibitors
granted -
US 11439611
Administration of serine protease inhibitors to the stomach
granted -
US 11432547
Inhibitors of GRB2-associated binding protein 1 (GAB1) and methods of treating cancer using the same
granted -
US 11433118
Long-acting VEGF inhibitors for intraocular neovascularization
granted -
US 11434233
Heterocyclic inhibitors of ATR kinase
granted -
US 11426393
Prolyl hydroxylase inhibitors and methods of use
granted -
US 11426420
Inhibitors of short-chain dehydrogenase activity for treating coronary disorders
granted -
US 11420936
Hypoxia inducible factor-2(alpha) inhibitors and their use in the treatment of diseases
granted -
US 11414379
SPAK kinase inhibitors as neuroprotective agents
granted -
US 11407712
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α
granted -
US 11407723
Selective histone deacetylase inhibitors for the treatment of human disease
granted -
US 11401286
Heteroaryl inhibitors of PDE4
granted -
US 11401246
Triazole glycolate oxidase inhibitors
granted -
US 11390646
Structure-based peptide inhibitors of α-synuclein aggregation
granted